Anders Liljeblad — CEO
Roles
31.08.2026 – 31.08.2026
Transactions (including via associated entities)
| Date | Issuer | Nature | Volume | Price | Value | Source |
|---|---|---|---|---|---|---|
| 31.08.2026 | Prostatype Genomics AB Stockholm | Other / unclassified via Liljeblad & Co Aktiebolag | 2,875,000 | — | No cash value 2,875,000 units | ↗ |
| 31.08.2026 | Prostatype Genomics AB Stockholm | Other / unclassified via Liljeblad & Co Aktiebolag | 1,437,500 | — | No cash value 1,437,500 units | ↗ |
| 31.08.2026 | Prostatype Genomics AB Stockholm | Bought — open marketAcquisition via Liljeblad & Co Aktiebolag | 5,750,000 | SEK 0.10 | SEK 575,000.00 | ↗ |